215 related articles for article (PubMed ID: 3918513)
21. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
Rashid M; Khairi A; Johnston C
Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
[No Abstract] [Full Text] [Related]
22. Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
Douglas DL; Duckworth T; Kanis JA; Preston C; Beard DJ; Smith TW; Underwood I; Woodhead JS; Russell RG
Arthritis Rheum; 1980 Oct; 23(10):1185-92. PubMed ID: 6448604
[TBL] [Abstract][Full Text] [Related]
23. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone.
Roux C; Gennari C; Farrerons J; Devogelaer JP; Mulder H; Kruse HP; Picot C; Titeux L; Reginster JY; Dougados M
Arthritis Rheum; 1995 Jun; 38(6):851-8. PubMed ID: 7779130
[TBL] [Abstract][Full Text] [Related]
24. Combined diphosphonate and calcitonin therapy for Paget's disease of bone.
Hosking DJ; Bijvoet OL
Calcif Tissue Res; 1976 Aug; 21 Suppl():321-6. PubMed ID: 821599
[No Abstract] [Full Text] [Related]
25. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
Drake S; Massie JD; Postlethwaite AE; Palmieri GM
Arch Intern Med; 1989 Feb; 149(2):401-3. PubMed ID: 2783843
[TBL] [Abstract][Full Text] [Related]
26. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
Gallacher SJ; Boyce BF; Patel U; Jenkins A; Ralston SH; Boyle IT
Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163
[TBL] [Abstract][Full Text] [Related]
27. The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.
Ralston SH; Boyce BF; Cowan RA; Fogelman I; Smith ML; Jenkins A; Boyle IT
J Bone Miner Res; 1987 Feb; 2(1):5-12. PubMed ID: 3137773
[TBL] [Abstract][Full Text] [Related]
28. Treatment of Paget's disease with intermittent low-dose infusions of disodium pamidronate (APD).
Stone MD; Hawthorne AB; Kerr D; Webster G; Hosking DJ
J Bone Miner Res; 1990 Dec; 5(12):1231-5. PubMed ID: 2075835
[TBL] [Abstract][Full Text] [Related]
29. A randomized clinical trial comparing oral alendronate and intravenous pamidronate for the treatment of Paget's disease of bone.
Walsh JP; Ward LC; Stewart GO; Will RK; Criddle RA; Prince RL; Stuckey BG; Dhaliwal SS; Bhagat CI; Retallack RW; Kent GN; Drury PJ; Vasikaran S; Gutteridge DH
Bone; 2004 Apr; 34(4):747-54. PubMed ID: 15050907
[TBL] [Abstract][Full Text] [Related]
30. Diphosphonates in Paget's disease.
Russell RG; Smith R; Preston C; Walton RJ; Woods CG
Lancet; 1974 May; 1(7863):894-8. PubMed ID: 4133419
[No Abstract] [Full Text] [Related]
31. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans.
Stein I; Shapiro B; Ostrum B; Beller ML
Clin Orthop Relat Res; 1977; (122):347-58. PubMed ID: 402246
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD).
Ryan PJ; Sherry M; Gibson T; Fogelman I
Br J Rheumatol; 1992 Feb; 31(2):97-101. PubMed ID: 1371084
[TBL] [Abstract][Full Text] [Related]
33. Biochemical response to combination of disodium etidronate with calcitonin in Paget's disease.
O'Donoghue DJ; Hosking DJ
Bone; 1987; 8(4):219-25. PubMed ID: 3128315
[TBL] [Abstract][Full Text] [Related]
34. Clinical and biochemical effects of EHDP in Paget's disease of bone: patterns of response to initial treatment and to long-term therapy.
Siris ES; Canfield RE; Jacobs TP; Stoddart KE; Spector PJ
Metab Bone Dis Relat Res; 1981; 3(4-5):301-8. PubMed ID: 6820111
[TBL] [Abstract][Full Text] [Related]
35. [Long-term experience using EHDP (ethylidene-1-hydroxy-1,1-diphosphonate) in the treatment of Paget's disease].
Sieghart S
Wien Med Wochenschr; 1986 Nov; 136(21-22):583-5. PubMed ID: 3103338
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of Paget's disease of bone: diphosphonates or calcitonin?].
Davoine GA; Jung A; Courvoisier B
Schweiz Med Wochenschr; 1981 Apr; 111(15):518-24. PubMed ID: 6785879
[TBL] [Abstract][Full Text] [Related]
38. Long-term follow-up of therapy with intermittent etidronate disodium in Paget's disease of bone.
Altman RD
Am J Med; 1985 Nov; 79(5):583-90. PubMed ID: 3933343
[TBL] [Abstract][Full Text] [Related]
39. [Moderate Paget's disease treated with pamidronate (APD): experience in 43 patients with a single 60 mg infusion of varying duration of 1-to-24 hours].
ThiƩbaud D; Portmann L; Burckhardt P
Schweiz Med Wochenschr; 1992 Dec; 122(49):1889-94. PubMed ID: 1462150
[TBL] [Abstract][Full Text] [Related]
40. The treatment of Paget's bone disease with sodium ethidronate.
Fromm GA; Schajowicz F; Casco C; Ghiringhelli G; Mautalen CA
Am J Med Sci; 1979; 277(1):29-37. PubMed ID: 106728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]